Inhibrx Biosciences (INBX)
Nasdaq • INBX • US45720N1037
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 30, 2026, ORTEX estimated 39.8% of free float sold short, 12.1 days to cover, cost to borrow 0.47%. Sign up for live short interest data.
Market Cap
1.22b USD | # 4668 in US
Volume
304.22k shares | 30.2m USD
Shares Outstanding
14.72m
Free Float Shares
58.29% | 8.58m
